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Summary
Background—WHO estimates exposure to air pollution from cooking with solid fuels is 
associated with over 4 million premature deaths worldwide every year including half a million 
children under the age of 5 years from pneumonia. We hypothesised that replacing open fires with 
cleaner burning biomass-fuelled cookstoves would reduce pneumonia incidence in young children.
Methods—We did a community-level open cluster randomised controlled trial to compare the 
effects of a cleaner burning biomass-fuelled cookstove intervention to continuation of open fire 
cooking on pneumonia in children living in two rural districts, Chikhwawa and Karonga, of 
Malawi. Clusters were randomly allocated to intervention and control groups using a computer-
generated randomisation schedule with stratification by site, distance from health centre, and size 
of cluster. Within clusters, households with a child under the age of 4·5 years were eligible. 
Intervention households received two biomass-fuelled cookstoves and a solar panel. The primary 
outcome was WHO Integrated Management of Childhood Illness (IMCI)-defined pneumonia 
episodes in children under 5 years of age. Efficacy and safety analyses were by intention to treat. 
The trial is registered with ISRCTN, number ISRCTN59448623.
Findings—We enrolled 10 750 children from 8626 households across 150 clusters between Dec 
9, 2013, and Feb 28, 2016. 10 543 children from 8470 households contributed 15 991 child-years 
of follow-up data to the intention-to-treat analysis. The IMCI pneumonia incidence rate in the 
intervention group was 15·76 (95% CI 14·89–16·63) per 100 child-years and in the control group 
15·58 (95% CI 14·72–16·45) per 100 child-years, with an intervention versus control incidence 
rate ratio (IRR) of 1·01 (95% CI 0·91–1·13; p=0·80). Cooking-related serious adverse events 
(burns) were seen in 19 children; nine in the intervention and ten (one death) in the control group 
(IRR 0·91 [95% CI 0·37–2·23]; p=0·83).
Interpretation—We found no evidence that an intervention comprising cleaner burning biomass-
fuelled cookstoves reduced the risk of pneumonia in young children in rural Malawi. Effective 
strategies to reduce the adverse health effects of household air pollution are needed.
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Funding—Medical Research Council, UK Department for International Development, and 
Wellcome Trust.
Introduction
Almost half of the world's population, including 700 million Africans, rely on biomass fuels 
for cooking (eg, animal dung, crop residues, wood, and charcoal).1–3 Although a billion 
people in sub-Saharan Africa are projected to gain access to electricity by 2040, 530 million 
will remain dependent on biomass fuels.4 Biomass fuel is typically burned in open fires, 
often indoors, leading to high levels of household air pollution from smoke. Women and 
children experience high exposures in and around the home due to gender-based domestic 
roles and these exposures have been linked to a range of adverse health outcomes, including 
chronic obstructive pulmonary disease, lung cancer, ischaemic heart disease, asthma, and 
pneumonia.1–3 Household air pollution from biomass fuel smoke is a leading cause of 
global disability and mortality with over 4 million deaths attributed to this exposure annually 
by WHO.3,5 This burden, including about half a million deaths due to pneumonia in young 
children, falls disproportionately on the poor, especially in sub-Saharan Africa. In Malawi, 
pneumonia is a leading cause of mortality among children younger than 5 years of age.6,7 
Over 95% of households depend on biomass for fuel and household air pollution levels are 
high and well beyond WHO safe limits.8,9 A substantial burden of pneumonia in young 
children might be attributable to biomass smoke exposure in this setting.
Two trials to assess the effects of interventions to reduce exposure to biomass smoke on 
health outcomes have been published to date.10,11 Both trials used stoves that reduce 
exposure mainly by venting emissions to the outdoor environment with a chimney rather 
than by improving combustion efficiency. Romieu and colleagues10 compared a Patsari 
stove intervention with the traditional open fire on respiratory symptoms and lung function 
in 552 women in Mexico. Adherence to the intervention was poor but the Patsari stove 
reduced respiratory symptoms (eg, rate ratio [RR] 0·29 [95% CI 0·11–0·77] for wheeze) and 
lung function decline (31 mL vs 62 mL over 1 year; p=0·01) in those who used the stove. 
The RESPIRE trial randomised 534 households with a pregnant woman or infant in highland 
Guatemala to a Plancha stove (with good compliance) or open fire and assessed the impact 
on pneumonia in children younger than 19 months.11 In intention-to-treat analyses the 
Plancha gave a non-significant reduction in incidence of physician-diagnosed pneumonia 
(primary outcome) (RR 0·84 [95% CI 0·63–1·13]; p=0·26; after multiple imputation to 
adjust for higher referral compliance among intervention homes, RR 0·78 [0·59–1·06]; 
p=0·10) and a significant reduction in physician-diagnosed severe pneumonia (RR 0·67 
[0·45–0·98]; p=0·04). There was a 50% reduction in personal child exposures (measured by 
carbon monoxide) but this improvement still left exposure levels well above WHO 
recommended limits.11 Cleaner burning biomass-fuelled cookstoves are now available that 
improve combustion efficiency by incorporating technologies (eg, electric fans and gasifier 
re-burning of evolved gases) that lead to a substantial, up to 90%, reduction in emissions in 
laboratory testing.12
Access to cleaner cooking fuels and technologies is limited by many factors in the 
developing world although poverty is a key underlying issue for most.13 The Global 
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Alliance for Clean Cookstoves (GACC) was launched in 2010 to tackle the lack of access to 
clean affordable energy through public–private partnerships. A central aim of GACC is for 
100 million homes to adopt clean cookstoves and fuels by 2020.14 However, there is limited 
evidence to assess the potential health benefits of such an approach: globally there are no 
data from clinical trials of cleaner burning biomass-fuelled interventions and in Africa there 
are no data from clinical trials of any cookstove interventions.3 We set out to determine 
whether a cleaner burning biomass-fuelled cookstove intervention would reduce pneumonia 
incidence in children under 5 years of age living in rural Malawi compared with 
continuation of traditional open fire cooking (see video).
Methods
Study design and participants
We did a cluster randomised controlled trial with two groups of equal size comparing the 
effects of a cleaner burning biomass-fuelled cookstove intervention with continued use of 
open fire cooking on pneumonia incidence in children under 5 years of age living in rural 
Malawi over a 2 year period (the Cooking and Pneumonia Study, CAPS). We defined 150 
community-level clusters within villages across two districts of Malawi where we had 
established field research sites: Chikhwawa in the southern Shire river valley and Karonga 
on the northern Malawi lakeshore. The Malawi College of Medicine Research Ethics 
Committee (ethics committee reference number P.11/12/1308) and the Liverpool School of 
Tropical Medicine Research Ethics Committee (ethics committee reference number 12.40) 
approved the protocol, which was peer reviewed, and a summary was published by The 
Lancet.15
Following community engagement exercises with village leaders and communities and the 
identification of a representative for each cluster, households with at least one child aged up 
to 4·5 years were invited to participate. Written informed consent (or witnessed thumbprint 
for those unable to read and write) was obtained at cluster and household level (parent or 
guardian of child) before participation. The trial was open to all consenting households with 
a usually resident child in the eligible age range. Households that became eligible for 
inclusion during the course of the trial (through birth, adoption, or in-migration) were 
recruited until 6 months before the trial ended.
Randomisation and masking
Clusters were randomly allocated to intervention and control groups using a computer-
generated randomisation schedule with stratification by site, distance from health centre, and 
size of cluster. Randomisation was done by the trial statistician using dummy codes A and B 
to represent intervention and control groups; to ensure the statistician remained masked, the 
identity (allocation) of A and B was determined by a second, independent statistician. The 
trial statistician used a dummy randomisation code to develop statistical programs for data 
analyses before unblinding the trial data.
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Procedures
Intervention households received two cleaner burning biomass-fuelled cookstoves (Philips 
HD4012LS; Philips South Africa, Johannesburg, South Africa), a solar panel to charge the 
battery for the stove fan, and user training. A fan incorporated into these cookstoves 
improves combustion efficiency; smoke emissions have been found to be reduced by around 
90% compared with the open fire in laboratory testing.12 Cookstoves were repaired and 
replaced as needed. Stove use monitors were placed on one of the stoves in a randomly 
selected 10% sample of intervention households at baseline and at the 12 month visit to 
provide an objective measure of use, by recording temperature fluctuations. Control 
households continued using traditional cooking methods (typically open fires). At the start 
of the trial control households were informed they would receive the intervention at the end 
of the study period for equity and to maximise retention. Each household was visited every 3 
months by fieldworkers although by the time the 21 month visit was due we were 3 months 
behind schedule and as such moved directly on to the final 24 month visit. Community 
engagement events were done regularly across all clusters to maintain engagement, facilitate 
discussion, and troubleshoot.
Outcomes
The primary outcome was the incidence of WHO Integrated Management of Childhood 
Illness (IMCI)-defined pneumonia in children under 5 years of age diagnosed by physicians, 
medical officers, or other appropriately trained staff at local health-care facilities routinely 
accessed by trial participants, unaware of intervention allocation.16
Secondary outcomes were the incidence of all pneumonia including those not meeting IMCI 
criteria, severe pneumonia, and death in children under 5 years of age. Additional outcomes 
included: the association between exposure to household air pollution and the development 
of pneumonia in children under 5 years of age in rural Malawi; prevalence and determinants 
of obstructive lung disease in adults in rural Malawi and the relationship between exposure 
to household air pollution and the rate of decline in lung function in adults in rural Malawi; 
affordability and cost-effectiveness of the intervention from household, health-care system, 
and societal perspectives; and what can be learned from trial participants and non-
participants about adoption of the intervention that could inform effective implementation of 
the trial findings in the future. The findings of these additional outcomes will be reported 
separately.
We provided training and equipment including respiratory rate timers, thermometers, and 
pulse oximeters to support local health services in delivering high quality clinical 
assessments and documentation of pneumonia diagnoses and severity assessments.17 A 
supply of antibiotics was provided when local health service stocks ran out.
The IMCI pneumonia assessment protocol was used because chest radiographs were not 
consistently available and were not part of the usual diagnostic work-up in rural Malawi. 
Non-severe IMCI pneumonia was defined as the presence of cough or difficulty breathing 
and fast breathing (60, 50, or 40 breaths per min or higher in those aged <2 months, 2–12 
months, and 1–5 years, respectively). Severe IMCI pneumonia was defined additionally by 
Mortimer et al. Page 5
Lancet. Author manuscript; available in PMC 2018 January 24.
 Europe PM
C Funders A
uthor M
anuscripts
 Europe PM
C Funders A
uthor M
anuscripts
chest in-drawing, stridor, or any general danger sign (inability to drink or breastfeed, 
vomiting, convulsions, lethargy, or unconsciousness). Oxygen saturation of less than 90% 
was included as an additional and objective marker of severity.
In Malawi there is a patient-held medical record system. Patients present their Malawi 
Ministry of Health and Population health passport whenever they seek medical care. All trial 
participants were provided with a new health passport if they did not already have one with 
sufficient blank pages. A sticker was inserted explaining that the child was in the trial; a 
brief summary of the IMCI pneumonia assessment protocol; and boxes to tick about clinical 
criteria and severity if the patient was diagnosed with pneumonia. Malaria was tested with a 
rapid diagnostic test and treated as indicated, as part of routine clinical practice. During or 
after the attendance, the trial team was notified about diagnoses of pneumonia and deaths by 
text or phone call from health facility based staff or a member of the household using a 
phone and airtime credit provided to each CAPS cluster representative.
Fieldworkers reviewed and captured digital images of the health passports of all children in 
the trial at visits every 3 months to obtain information about episodes of pneumonia and 
deaths not otherwise reported. Electronic case report forms programmed using Open Data 
Kit (ODK; Department of Computer Science and Engineering, University of Washington, 
Seattle, WA, USA) software and administered by smartphone (Samsung Galaxy S3) were 
used to collect these data. Data were transferred from smartphones to a secure server at each 
study site, checked, uploaded to a database, cleaned, and then relayed onwards to a central 
secure server in preparation for analysis. Source document verification was done for every 
case of pneumonia using digital images of health records as source documents by a single 
member of the study team, the methodology for which was reviewed and approved at a Pan 
African Thoracic Society meeting in Malawi in July, 2016.18
Data about cooking-related adverse events were collected at field visits every 3 months. 
Adverse events that met seriousness criteria (death, life-threatening, led to hospitalisation or 
prolongation of an existing hospitalisation, or led to disability or incapacity) were reported 
immediately to the trial coordinating centre for assessment of causality, seriousness, and 
expectedness, and for appropriate medical action and onward reporting to be arranged. An 
independent data monitoring committee reviewed all potentially cooking-related serious 
adverse events.
Statistical analysis
We aimed to include 150 clusters representing an estimated 10 600 eligible children. 
Clusters were randomised in equal numbers to two intervention groups to provide, over the 
whole study period, about 21 200 child-years of follow-up and 90·3% power to detect a 
reduction in the rate of pneumonia from five per 100 child-years in the control group to four 
per 100 child-years in the intervention group (proportionally, a 20% reduction). This 
conservative estimate of incidence was used to allow for potential reductions in the rate of 
pneumonia following pneumococcal vaccine introduction. We assumed an effective intra-
cluster correlation (ICC) of 0·10 and a coefficient of variation in cluster size of 30–35%. Full 
sample size considerations are available online.
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All primary analyses used intention-to-treat principles; the intention-to-treat population was 
all participants with at least one follow-up record before reaching 5 years of age. Secondary 
per-protocol analyses were also done; the per-protocol population included all participants 
54 months of age or younger at recruitment and, in the intervention group, participants from 
households with at least one follow-up record at which stove use was reported. Generalised 
estimating equation (GEE) modelling methods were used to assess the primary outcome, 
adjusting for clustering effects. Covariate adjusted analysis was done on the primary 
outcome by adding the following prespecified variables into the above GEE model: district, 
age of child at recruitment, sex, distance to nearest health centre, number of children 
younger than 5 years living in household, number of people in household who smoke 
regularly, other sources of fire or smoke (other than cooking) to which child was exposed on 
a daily (or almost daily) basis, socioeconomic status of household, number of previous 
pneumonia episodes experienced by child, and status of childhood vaccinations. Secondary 
outcomes were analysed similarly using GEE models; time to event data were analysed 
using Cox regression model with frailty for the cluster effect. One masked interim safety 
analysis was done and reviewed by the data monitoring committee to determine whether 
there were grounds to stop the trial for safety. Provision for an interim analysis for efficacy 
was included in the protocol although was not required by the data monitoring committee. 
SAS statistical package (version 9.3) was used. The full peer-reviewed statistical analysis 
plan is available online. The study is registered with ISRCTN, number ISRCTN59448623.
Role of the funding source
The funders had no role in the study design, data collection, analysis, interpretation, or 
writing of the report. The corresponding author had full access to all the study data and had 
final responsibility for the decision to submit for publication.
Results
We enrolled 10 750 children from 8626 households across 150 community-level clusters in 
two sites in rural Malawi between Dec 9, 2013, and Feb 28, 2016. 207 children were lost to 
follow-up (103 from the intervention group and 104 from the control group) from 156 
households (83 in the intervention group and 73 in the control group) between baseline and 
first follow-up visit (figure). Data were therefore available from 10 543 children (5297 in the 
intervention group and 5246 in the control group) from 8470 households (4256 in the 
intervention group and 4214 in the control group) for at least one follow-up visit and form 
the intention-to-treat and safety dataset (figure). Baseline characteristics were balanced 
between intervention and control groups (table 1). There were 15 991 child-years of follow-
up (7964 child-years from the intervention group and 8027 child-years from the control 
group). The last participant follow-up visit was on Sept 14, 2016.
We excluded 47 children (21 in the intervention group and 26 in the control group) because 
they were aged over 54 months at recruitment and 25 children from intervention households 
due to self-reported never use of the intervention to create the per-protocol population. The 
per-protocol population was therefore 10 471 children (5251 in the intervention group and 
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5220 in the control group) from 8429 households (4224 in the intervention group and 4205 
in the control group).
There were 2506 episodes of IMCI pneumonia in the overall intention-to-treat population 
(1255 in the intervention group and 1251 in the control group) giving an incidence rate of 
15·67 (95% CI 15·06–16·28) per 100 child-years. The incidence rate in the intervention 
group was 15·76 (95% CI 14·89–16·63) per 100 child-years and in the control group 15·58 
(95% CI 14·72–16·45) per 100 child-years, with an incidence rate ratio (IRR) of 1·01 (95% 
CI 0·91–1·13; p=0·80). The estimated ICC was 0·03. After adjustment for baseline values, 
the IRR for IMCI pneumonia for the intervention versus control was 1·05 (95% CI 0·93–
1·18; p=0·44). The incidence rate for IMCI pneumonia in the overall per-protocol population 
was 15·70 (95% CI 15·09–16·32) per 100 child-years with an intervention versus control 
IRR of 1·02 (95% CI 0·91–1·14; p=0·77). The hazard ratio for time from enrolment to first 
pneumonia episode in the intervention versus control group was 1·06 (95% CI 0·93–1·21; 
p=0·29). The incidence rate for all pneumonia episodes including those not meeting IMCI 
criteria was 17·21 (95% CI 16·57–17·85) per 100 child-years with an intervention versus 
control IRR of 1·02 (95% CI 0·91–1·13; p=0·75).
In the intervention versus control group the IRR for severe pneumonia episodes defined by 
IMCI criteria was 1·30 (0·99–1·71; p=0·06), for oxygen saturation less than 90% 1·56 (0·70–
3·46; p=0·28), and for death 0·76 (0·17–3·37; p=0·71; table 2). A rapid diagnostic test for 
malaria was done at the time of IMCI pneumonia diagnosis in 1547 cases, of which 473 
(30·6%) were positive.
At the first (3 months), 12, and 24 month follow-up visits, 73·3% (2535 of 3457), 59·0% 
(1889 of 3204), and 49·8% (1414 of 2841) of intervention households, respectively, reported 
that the cookstoves met all their cooking needs. Most households that answered an optional 
follow-up question reported using the stoves for at least one meal a day on average over the 
2 years of follow up (table 3). The most common reason given for not using the cookstoves 
for all cooking tasks was that the cookstoves had malfunctioned; battery failures were 
particularly common. We placed 364 stove use monitors on one of the two cookstoves in 
households selected for this sub-study from which 537 (36·9%) of a potential 1456 sets of 
usable data were obtained during year 1 and 498 (45·6%) of a potential 1092 sets for year 2. 
The mean number of cooking events per day for the monitored cookstove was 0·51 (SD 
0·55) during year 1 and 0·34 (0·40) during year 2. Over the course of the trial, repairs or 
replacements were done on 13 192 (3·1 per intervention household) occasions for 
cookstoves and 5259 (1·2 per intervention household) occasions for solar panels. Control 
households were provided with two advanced cookstoves (ACE-1; African Clean Energy 
Company, Maseru, Lesotho) with a solar charger and solar lamp (part of the standard 
cookstove package by this time) at the end of the trial.
596 serious adverse events were reported excluding pneumonia. With the exception of a 
borderline statistically significant increased risk of malaria in the intervention group (IRR 
1·32 [95% CI 1·03–1·69]; p=0·03) there were no differences in incidence rates of serious 
adverse events between the intervention and control groups (table 4). Of these, 19 (nine in 
the intervention group and ten in the control group) were cooking-related burns (IRR 0·91 
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[95% CI 0·37–2·23]; p=0·83). Additionally, 1505 burns (549 in the intervention group and 
956 in the control group) not meeting seriousness criteria were reported (IRR 0·58 [95% CI 
0·51–0·65]; p<0·0001). There were 53 deaths (malaria [14], pneumonia [seven], sepsis 
[five], malnutrition [five], accidental injury [four], gastroenteritis [one], burns [one], and 
other or unknown [16]) from the time of enrolment, 44 (25 in the intervention group and 19 
in the control group) of which occurred in the intention-to-treat population (IRR 1·32 [95% 
CI 0·73–2·40]; p=0·36). The data monitoring committee reviewed trial safety data in March, 
2015, and found no grounds to stop the trial early.
Discussion
This community-level cluster randomised controlled trial in Malawi is the largest trial of a 
cookstove intervention on health outcomes to date. Malawi is one of the world's poorest 
countries and within particularly impoverished rural areas it is frequent for households to 
have insufficient money at times to buy basic items like soap or food for their normal meals. 
The intention-to-treat analysis included data from 10 543 children from 8470 households 
across 150 community-level clusters representing 15 991 child-years of follow-up data. The 
number of children included was close to our original sample size estimate of 10 600 
although the total follow-up time was less than the estimated 21 200 child-years. The 
incidence rate of IMCI pneumonia was high (15·67 per 100 child-years) and about three 
times higher than the deliberately conservative assumption used for our sample size 
calculation (five per 100 child-years). The observed incidence rate was more in agreement 
with 2010 estimates of IMCI pneumonia incidence in Malawi (24·3 per 100 child-years).19 
Baseline characteristics were well balanced between the intervention and control groups. 
The intention-to-treat and per-protocol analyses with and without adjustment for baseline 
data were consistent in finding no effect of the intervention on the incidence of IMCI 
pneumonia in the young children in the study. Although limited by a smaller number of 
cases, analyses restricted to severe pneumonia episodes similarly found no beneficial effect 
of the intervention.
The intervention comprised a package of two cleaner burning biomass-fuelled cookstoves to 
provide two cooking hobs, a solar charger for the battery in the cookstove, a repair and 
replacement service, and user training. The intervention cookstove was selected on the basis 
of being among the cleanest burning biomass-fuelled cookstoves available at the time we 
designed the trial, with 90% lower emissions than open fires in laboratory tests.12 The repair 
and replacement service was heavily used, with each intervention household requiring this 
service four times on average over the course of the trial. The high rate of cookstove and 
solar charger malfunction was surprising since these products had been specifically designed 
and developed for the indications, end users, and environments in which we assessed them. 
Failure of the rechargeable lead acid batteries in the cookstoves was a particularly common 
problem requiring replacement of the batteries. This issue could have been largely avoided 
had the cookstoves had better quality batteries. Cookstove malfunction was the most 
common reason given by households for not using the cookstoves for all cooking needs. 
Although we did repairs and replacements as quickly as possible there were inevitably short 
periods when households only had one functioning cookstove. When this alone was not 
sufficient for all cooking needs the household would have had to revert to using the open 
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fire. Nevertheless, and despite these challenges, self-reported use of the cookstoves was 
probably as high as could be realistically expected with three-quarters of intervention 
households reporting the use of the stoves for all their cooking needs at 3 months, reducing 
to about half of households after 2 years; as is true in kitchens around the world there is no 
single cooking device suitable for every task.
We included stove use monitors on one of two cookstoves in a subset of intervention 
households to provide an objective measure of use. Although these monitors generated less 
usable data than anticipated due to technical problems, and their presence on just one of the 
two stoves might have affected which stove was used, they similarly indicate a waning in use 
over time. The impact on pneumonia in children might have been greater had adoption of the 
intervention been higher but the levels of adoption we achieved are probably higher than 
would be the case outside the context of a trial, particularly if an intensive and free repair 
and replacement service was not available.
Baseline data showed that in addition to almost exclusive use of biomass fuels for cooking, 
exposure to smoke from other sources including burning of rubbish, tobacco, and income 
generation activities was a common day-to-day experience. Additionally, as cookstoves were 
only issued to households that had a resident child younger than 5 years, exposure to smoke 
from neighbours’ or relatives’ cooking fires is likely. It is thus possible that these other air 
pollution exposures would have negated any potential beneficial impact of the cookstove 
intervention and that had even cleaner burning cookstoves been used, they would be unlikely 
to have had an impact. Personal exposure and exposure-response data, to be published 
separately, will provide additional insights here.
There was a high incidence of serious adverse events unrelated to cooking across the trial 
population reflecting the expected range and frequency of serious childhood illnesses seen in 
rural Malawi. There was a borderline statistically significant increased risk of malaria in the 
intervention versus the control group, which might be a false positive finding reflecting 
multiplicity of secondary safety analyses. Data from elsewhere suggest smoke from open 
fire cooking is unlikely to protect against malaria vectors.20 Nevertheless, this is an area of 
uncertainty and this observation warrants further investigation. Serious adverse events 
related to cooking (all burns) resulted in considerable morbidity and one death in our study 
population. Less serious burns were a common occurrence with 508 (4·8%) of 10 543 
children reporting a burn in the 3 months before study enrolment and 1505 burns not 
meeting seriousness criteria reported during the study. Although serious burns were evenly 
distributed across the trial groups, there was a substantial 42% reduction (IRR 0·58 [95% CI 
0·51–0·65]; p<0·0001) in risk of non-serious burns in the intervention group, suggesting the 
intervention offers considerable safety advantages over the open fire.
The findings of our trial add substantially to the trials of chimney stoves in Mexico (552 
women followed up for 10 months) and Guatemala (518 children from 534 households 
contributing 560 child-years of follow-up).10,11 Although none found a statistically 
significant effect on the primary health outcome of interest, all point to benefits of the 
interventions in secondary analyses—there was a reduction in burns in Malawi, a reduction 
in respiratory symptoms, and decline in lung function in adults in a per-protocol analysis of 
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intervention adopters in Mexico, and a reduction in severe acute lower respiratory tract 
infections in Guatemala.
Although the design of our trial was necessarily open, considerable effort was put into 
minimising the risk of bias associated with a non-blinded study. Specifically, we provided 
training to fieldworkers to ensure participants were treated in the same way irrespective of 
trial group; scheduled the same frequency offield visits to intervention and control villages; 
collected primary outcome data in the same way for intervention and control villages; 
provided training to local health-care workers about how to make an IMCI diagnosis of 
pneumonia, the importance of carrying out assessments, and treatment based on clinical 
need and without enquiring about trial allocation to achieve blinded assessment of the 
primary outcome; and did blinded independent source document verification for all 
pneumonia diagnoses. The trial was done in a challenging environment where poverty is 
widespread and health services are stretched. We used the widely adopted WHO IMCI 
diagnostic criteria for pneumonia implemented by independent health-care workers because 
this approach is most reflective of the reality on the ground where access to more 
sophisticated diagnostic tools such as chest radiographs are not consistently available. 
Although this pragmatic approach might lack specificity, it is the best measure of the entity 
reported as pneumonia and associated with morbidity and mortality among children under 5 
years of age in Malawi and elsewhere in sub-Saharan Africa.
In conclusion, we found no evidence of a reduction in pneumonia in young Malawian 
children in a rigorously conducted clinical trial of a cleaner burning biomass-fuelled 
cookstove intervention. The lack of effect on pneumonia might be explained by exposure to 
other sources of air pollution, including rubbish burning and tobacco smoke, that could have 
overwhelmed any potential effects of the cookstoves. It is also possible that the cookstoves 
used simply did not reduce emissions sufficiently to have an effect. An important 
implication of these observations is that tackling any individual source of air pollution 
exposure in isolation is unlikely to be effective for improving health; an integrated approach 
to achieving clean air that tackles rubbish disposal, tobacco smoking, and other exposures, 
as well as robust cleaner cooking solutions (eg, cleaner stoves and fuels) that achieve a high 
rate of acceptance is probably needed to deliver health benefits.21
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research in context
Evidence before this study
Results of two trials assessing the effects of interventions to reduce exposure to biomass 
smoke on health outcomes were published before this study. Both tested stoves that 
reduce exposure mainly by venting emissions to the outdoor environment via a chimney 
rather than by improving combustion efficiency. Romieu and colleagues compared a 
chimney stove intervention with traditional open fire on respiratory symptoms and lung 
function in 552 women in Mexico. Adherence to the intervention was poor but the 
chimney stove reduced respiratory symptoms and lung function decline in those who 
used the stove. The RESPIRE trial randomised 534 households with a pregnant woman or 
infant in highland Guatemala to a chimney stove (with good compliance) or open fire and 
assessed the impact on pneumonia in children younger than 19 months. In intention-to-
treat analyses, there was a non-significant reduction in incidence of physician-diagnosed 
pneumonia (primary outcome) in the chimney stove group (rate ratio [RR] 0·84 [95% CI 
0·63–1·13]; p=0·26) and a significant reduction in physician-diagnosed severe pneumonia 
(RR 0·67 [0·45–0·98]; p=0·04).
Added value of this study
This trial is the largest study of the effects of a biomass-fuelled cookstove intervention on 
health outcomes to date. The trial was done in very resource-poor populations in rural 
Malawi where pneumonia is one of the leading causes of morbidity and mortality in 
young children and almost all households burn biomass fuels for cooking. Data from 10 
543 children from 8470 households across 150 community-level clusters contributed 15 
991 child-years of follow-up data to the intention-to-treat analysis. The intervention 
comprising two biomass-fuelled cookstoves, a solar charger, repair and maintenance 
service, and user training had no effect on the risk of pneumonia in children under the age 
of 5 years in rural Malawi.
Implications of all the available evidence
There is insufficient evidence on which to recommend replacing open fires with biomass-
fuelled cookstoves for the prevention of pneumonia in young children in settings where 
biomass fuels are burned in open fires for cooking.
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Figure. Trial profile
ITT=intention to treat.
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Table 1
Baseline characteristics of the intention-to-treat population
Intervention Control
Individual-level data
Number of children 5297 5246
Age (months)     24·5 (16·1)     23·8 (16·1)
Sex
   Male 2641 (49·9%) 2561 (48·8%)
   Female 2656 (50·1%) 2685 (51·2%)
Vaccination status (course completed)*
   Diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B 2893 (79·4%) 2980 (79·4%)
   Pneumococcal conjugate 2122 (58·3%) 2239 (59·7%)
   Polio 2726 (74·8%) 2857 (76·1%)
   Rotavirus 1713 (47·0%) 1774 (47·3%)
   Measles 2166 (59·5%) 2228 (59·4%)
Had pneumonia at least once in the preceding 12 months†   762 (15·4%)   844 (17·4%)
Had a cooking-related burn in the preceding 3 months 219 (4·1%) 289 (5·5%)
Household-level data
Number of households 4256 4214
Fuel used regularly for cooking‡
   Wood 2494 (58·6%) 2390 (56·7%)
   Crop residues 1339 (31·5%) 1320 (31·3%)
   Charcoal   563 (13·2%)   723 (17·2%)
   Dung   20 (0·5%)   25 (0·6%)
   Electricity     5 (0·1%)   13 (0·3%)
   Paraffin/kerosene     2 (0·0%)     6 (0·1%)
   Gas       0     2 (0·0%)
   Other     2 (0·0%)       0
Tobacco smoker in the household   746 (17·5%)   634 (15·0%)
Daily or almost daily exposure to smoke from:‡
   Burning rubbish 1747 (41·0%) 1677 (39·8%)
   Cooking for business   554 (13·0%)   513 (12·2%)
   Brick production 177 (4·2%) 214 (5·1%)
   Paraffin/kerosene lamps   87 (2·0%) 105 (2·5%)
   Mosquito coils   44 (1·0%)   82 (1·9%)
   Beer production   54 (1·3%)   44 (1·0%)
   Other sources   63 (1·5%)   47 (1·1%)
Source of drinking water‡
   Bore hole 1900 (44·6%) 1973 (46·8%)
   Tap to house 401 (9·4%) 378 (9·0%)
   Shared communal tap 389 (9·1%) 324 (7·7%)
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Intervention Control
   Covered well 254 (6·0%) 233 (5·5%)
   Lake or river 255 (6·0%) 157 (3·7%)
   Open well 191 (4·5%) 253 (6·0%)
   Other     3 (0·1%)     1 (0·0%)
Toilet facilities
   Simple pit latrine 3448 (81·0%) 3553 (84·3%)
   None   763 (17·9%)   612 (14·5%)
   Water toilet   37 (0·9%)   23 (0·5%)
   Ventilated improved pit     8 (0·2%)   26 (0·6%)
Experienced a time in the last year when there was not enough food for the household to have its normal 
meals
2131 (50·1%) 2113 (50·1%)
Experienced a time in the last year when the household did not have money to buy bathing soap 2608 (61·3%) 2597 (61·6%)
Data are mean (SD) or n (%).
*Vaccination status available for 7395 children (3642 in the intervention group and 3753 in the control group).
†
Data available for 9798 children (4954 in the intervention group and 4844 in the control group).
‡
Household could give multiple responses.
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Table 2
Incidence rate and incidence rate ratio of severe pneumonia defined according to IMCI 
criteria, oxygen saturation less than 90%, or death
Intervention (n=5297) Control (n=5246) Incidence rate 
ratio (95% CI)
p value
Number of cases Incidence rate 
(cases per 100 
child-years, 95% 
CI)
Number of cases Incidence rate 
(cases per 100 
child-years, 95% 
CI)
IMCI criteria 186 2·33 (2·00–2·67) 145 1·80 (1·51–2·09) 1·30 (0·99–1·71) 0·06
Oxygen saturation <90%   17 0·21 (0·11–0·31)   11 0·14 (0·06–0·22) 1·56 (0·70–3·46) 0·28
Death     3 0·04 (0·00–0·08)     4 0·05 (0·00–0·10) 0·76 (0·17–3·37) 0·71
IMCI=WHO Integrated Management of Childhood Illness.
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Table 3
Meals cooked using intervention cookstoves at 3, 12, and 24 month follow-up visits
3 months (n=922) 12 months (n=1315) 24 months (n=1427)
None   73 (7·9%) 333 (25·3%) 312 (21·9%)
1 meal per day 248 (26·9%) 339 (25·8%) 524 (36·7%)
1–2 meals per day 213 (23·1%) 301 (22·9%) 215 (15·1%)
2 or more meals per day 388 (42·1%) 342 (26·0%) 376 (26·3%)
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Table 4
Incidence rate and incidence rate ratio of serious adverse events excluding pneumonia
Intervention (n=5297) Control (n=5246) Incidence rate ratio 
(95% CI)
p value
Number of events Incidence rate 
(cases per 100 
child-years, 95% 
CI)
Number of events Incidence rate 
(cases per 100 
child-years, 95% 
CI)
Malaria  175   2·19 (1·87–2·52)  134   1·66 (1·38–1·95)   1·32 (1·03–1·69)   0·03
Sepsis    51   0·64 (0·46–0·82)    54   0·67 (0·49–0·85)   0·95 (0·64–1·41)   0·81
Gastroenteritis    24   0·30 (0·18–0·42)    28   0·35 (0·22–0·48)   0·86 (0·49–1·53)   0·62
Burns      9   0·11 (0·04–0·19)    10   0·12 (0·05–0·20)   0·91 (0·37–2·23)   0·83
Accidental injury    12   0·15 (0·07–0·24)      9   0·11 (0·04–0·18)   1·42 (0·58–3·45)   0·44
Malnutrition      5   0·06 (0·01–0·12)      5   0·06 (0·01–0·12)   1·01 (0·29–3·48)   0·99
Asthma      6   0·08 (0·02–0·14)      2   0·02 (0·01–0·06)   3·03 (0·51–18·11)   0·22
Other    36   0·45 (0·30–0·60)    36   0·45 (0·30–0·59)   1·02 (0·62–1·66)   0·94
Total  318   3·99 (3·55–4·43)  278   3·45 (3·05–3·86)   1·15 (0·95–1·38)   0·15
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